A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression

Yue Teng1, Xiaohang Zuo, Meng Hou

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, China.

Abstract

Insights

This study reveals miR-29b regulates DNA methylation in ovarian cancer by targeting DNMT3A/3B. This epigenetic feedback loop offers potential for new miR-29b-based ovarian cancer therapies.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Epigenetic abnormalities are common in epithelial ovarian cancer (EOC).
  • Tumor-suppressor microRNAs (epi-miRNAs) can counteract these abnormalities.
  • miR-29b is a known epi-miRNA with potential roles in EOC.

Purpose of the Study:

  • To investigate the role of miR-29b in DNA methylation regulation in EOC cells.
  • To elucidate the relationship between miR-29b and DNA methyltransferases (DNMTs) in EOC.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR), western blotting, and immunohistochemistry assessed miR-29b and DNMT3A/3B expression.
  • Functional roles were tested using anti-miRs and microRNA precursors.
  • Luciferase reporter assays and Co-immunoprecipitation (Co-IP) investigated direct interactions.

Main Results:

  • miR-29b expression was inversely correlated with DNMT3A/3B levels in EOC.
  • miR-29b directly targeted DNMT3A/3B mRNAs, leading to their downregulation.
  • A double-negative feedback loop was identified: DNMT3A/3B modulated miR-29b expression via DNA methylation, and miR-29b regulated DNMT3A/3B.

Conclusions:

  • A novel epigenetic regulatory circuit involving miR-29b and DNMT3A/3B was uncovered in EOC.
  • This crosstalk suggests potential for miR-29b-based therapeutic strategies for EOC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K